31 results about "Psychological addiction" patented technology

A method for predicting nicotine replacement dosage to achieve a target nicotine serum concentration relies on measuring blood nicotine concentration prior to smoking cessation. At least two values corresponding to other patient characteristics, such as body mass, cumulative smoking, psychological dependence, age, and menopausal status, are also determined and used to predict expected blood nicotine concentrations based on nicotine replacement dosages. Such methods are useful in achieving target blood nicotine concentrations for smoking cessation and therapy.

The invention discloses application of lithium salt in preparing a medicine for treating psychostimulant addiction and application of the lithium salt in preparing a medicine for preventing the relapse after psychostimulant detoxication. The invention provides an effective way for treating drug addiction caused by behavioral sensitization of psychostimulants (such as cocaine, and the like); moreover, the invention has good effect and can radically improve the psychological dependence of psychostimulant addicts.

The invention discloses a conotoxin analog Glu-Con-G[1-13], which is shorter than a Con-G peptide chain and small in molecular weight, and is obtained by replacing Gla3, Gla4, Gla7, Gla10 and Gla14 of the Con-G by natural amino acid Glu. The invention improves the defect that a Gla residue is hard to obtain to some extent. The Glu-Con-G[1-13] keeps the original activity, namely has certain interference effect on psychological dependence and physical dependence on morphine, is more easily synthesized artificially, and has smaller molecular weight of 1,588; however, the molecular weights of the Con-G and Glu-Con-G are respectively 2,265.19 and 2,044.14.

The invention discloses health-care food for improving sleep. The health-care food is characterized by being prepared from the following raw materials in part by weight: 5 to 45 parts of Chinese magnoliavine fruit, 10 to 50 parts of spina date seed, 5 to 25 parts of American ginseng, 7 to 65 parts of platycladi seed, 5 to 15 parts of valerian root and 435 to 1,205 parts of corn oil. Due to the adoption of a pure Chinese medicinal preparation, the health-care food does not have side effect and psychological dependence on human bodies, has an obvious effect on symptoms such as neurasthenia, insomnia, dreaminess and the like, has the total effective rate of over 95 percent, and can improve disharmony of yin and yang of the human bodies fundamentally to reach balance.

The invention provides smoking cessation tea and a preparation method thereof. Protospecies liu pao tea and five purely natural Chinese herbal medicines without side effect are adopted. The smoking cessation tea comprises the following components in parts by weight: 30-50 parts of liu pao tea, 8-12 parts of malt, 5-10 parts of pericarpium citri reticulatae, 10-13 parts of gypsum, 5-8 parts of elecampane and 10-15 parts of liquorice root. The components are prepared into a tea product with a conventional processing method. The smoking cessation tea has the function of removing body toxin, enhancing constitution and reducing dependence on smoke according to the mechanism of smoking addiction by the treatment principle of clearing heat, expelling toxin and righting qi in the traditional Chinese medicine. After a smoking quitter quits smoke, the tea can firstly decompose nicotine hormone in blood quickly to quicken blood circulation and excretion and get rid of psychological addiction troubles; then, endorphin (EP) which stops secreting in the body of the smoking quitter because of smoking is aroused to secrete again; and dependence on cigarettes can be fundamentally solved no matter how deep the smoking addiction degree is and how long the smoking year is so that the smoking addiction is easily quitted.

The invention relates to a bag-packaged tea capable of treating insomnia, belonging to the technical field of functional beverage. Insomnia is a stubborn disease, and brings great pain and psychological load to patients, and people with serious insomnia may have neurasthenic, and the western medicines for treating insomnia have side effect and may causes psychological dependence when used for a long term. The bag-packaged tea capable of treating insomnia disclosed by the invention is safe, has no any side effect, and comprises 1-2 parts of cortex albizziae, 1 part of polygala and 2-3 parts of pachyma cocos.

The invention relates to an anti-relapse drug-breaking medicine, which mainly comprises ginsengs, figwirt roots, red sage roots, indian breads, atractylodes rhizomes, zedoaries, earth worms, corydalis tubers, roots of herbaceous peony, spiny jujube seeds, anemarrhenas, Polygala roots, Chinese angelica roots, rhizome of Sichuan lovages, roots of paniculate swallowwort, dandehon herbs, oldenlandias, bitter cardamons, and licorices. The whole medicinal formula adjusts the equilibrium between yin and yang and cures dialectically according to the Chinese medicine theory, the therapeutic modalities of poison elimination and abstinence, poison cleansing and poison excreting, body resistance strengthening, and temporary solution and permanent cure of the Chinese traditional medicine are fully exerted, the relapse is prevented, the psychological dependence is eliminated after the detoxification, through adjusting the whole functions of human body, the abstinence symptoms are controlled and alleviated, the immunity of the patient is enhanced, the body condition of the patient is improved, to attain the purpose of preventing and curing the relapse and speeding up the recovery.

The embodiment of the invention provides a method, device and system for monitoring the psychological addiction state of a drug abstainer in real time. The method comprises: a mobile head-mounted device acquires an electroencephalogram signal of the drug abstainer in real time; the mobile head-mounted device analyzes the electroencephalogram signal, and extracts a feature vector reflecting the psychological addiction state of the drug abstainer; the mobile head-mounted device judges whether the drug abstainer is in a psychological addiction attack state according to the feature vector; and the mobile head-mounted device sends a judgment result to a monitoring terminal. The method can be used for carrying out real-time monitoring by acquiring the electroencephalogram signal, and the psychological addiction attack state can be accurately and effectively judged.

The invention discloses an application of rapamycin in preparing medicines for treating addiction to morphine-like drugs. The invention provides an effective method for treating addiction to morphine-like drugs and preventing addicts taking morphine-like drugs again after detoxication of morphine-like drugs. The medicines have good therapeutic effect, and are hopeful to completely eliminate the psychological dependence of people addiction to morphine-like drugs.

The invention discloses a traditional Chinese medicine compound for drug addiction treatment. The ingredients of the traditional Chinese medicine compound are selected from natural medicinal materials, and the traditional Chinese medicine compound belongs to the field of medicines. The traditional Chinese medicine compound is prepared from 15 traditional Chinese medicines, including coptis chinensis, scutellaria baicalensis, jasmine, radix curcumae, corydalis tuber, angelica sinensis, bezoar, radix paeoniae alba, polygala tenuifolia, spina date seeds, ginseng, astragalus membranaceus, poria cocos, radix aconiti carmichaeli and liquorice. The traditional Chinese medicine compound for drug addiction treatment, disclosed by the invention, is wider in application scope, lower in toxicity and better in curative effect; the traditional Chinese medicine compound can thoroughly eliminate vivotoxin, is free from toxic or side effect and can not cause physiological or psychological dependence; and after a patient takes the traditional Chinese medicine compound for treating drug addiction, the patient has a strong disgusting feel if the patient contacts with the drug again, so that the relapsing phenomenon can be overcome.

The invention relates to a method for determining the psychological dependence degree of drug man on opium drug, belonging to technology field of addiction medicine and neuro-biology. The invention is characterized by fast, accurate and reliable.

The invention provides a narcotic-abstaining addiction-removing traditional Chinese medicine composition, a corresponding smoking product and a preparation method thereof. The composition comprises the following components according to parts by weight: 3-8 parts of licorice, 4-12 parts of aloe, 80-100 parts of corydalis tuber, 5-8 parts of Chinese date kernel, 5-8 parts of radix salviae miltiorrhizae, 5-8 parts of faxia, 5-8 parts of seed of jog's tears, 4-5 parts of rhizoma acori graminei, 2-4 parts of prepared arisaema cum bile, 1-4 parts of Chinese ephedra, 1-4 parts of pine needle, 4-5 parts of Chinese tetrandra root, 2-4 parts of radix notoginseng, 1-6 parts of ginseng and 15-20 parts of corn silk. The preparation method comprises the following steps: extracting part of the raw materials in the composition into an extract, pulverizing the rest part, then mixing, pressing into laminar silk, rolling to prepare a cigar type narcotic-abstaining smoking product. The invention especially has an obvious control action on the psychological addiction, the insomnia and the angst of a narcotic-abstaining person and can achieve the effects of quick acting, high efficiency and long lasting.

The present invention provides a use of a lannaconitine compound to treat psychological dependence of addictive substances. Particularly, the disclosed lannaconitine compound or pharmaceutically acceptable salts thereof are used for (a) prevention and / or treatment of psychological dependence of addictive substances; (b) reduce psychological dependence drug addiction of addictive drugs; and / or (c)reduce probability of relapse (or reuse) of the addictive substances in subjects who have successfully detoxified. Experiments show that the lannaconitine compound can effectively treat the psychological dependence of morphine, alcohol and other addictive substances, reduce chance of the relapse of the addictive substances by the detoxified subjects and help the detoxified subjects completely getrid of addiction.

The invention relates to a quick drug detoxification capsule which utilizes the pure natural plants and animals medicinal materials such as ginseng, bear bile powder, costus root, houttuynia cordata, frankincense, myrrh, gardenia, processed fumitory, artificial bezoar, shinyleaf pricklyash root, rhizoma gastrodiae, aconite, caulis polygoni multiflori, himalayan teasel root, processed henbane, rhubarb, earthworm, date core, donkey-hide glue, aweto, panax notoginseng, pilose antler, and other materials, which are processed into tiny powders and then into capsules. The capsule of the invention is quick in drug detoxification, nonirritating and has no toxic and side effect, and can relieve the pain of the drug taker in the greatest degree and eliminate the physical and psychological dependence of drug takes, without any new dependence, so the capsule of the invention can help achieve the aim of drug detoxification and recovery.

The invention relates to the application of baclofen in the opium drug abstinence treatment and belongs to the technical field of addiction medicine application. According to the characteristic of baclofen GABA beta-receptor stimulant, the invention applies the baclofen with the daily dosage of 15 to 120mg as the drug for the opium drug abstinence treatment by virtue of the mutual reaction relation between the baclofen GABA beta-receptor stimulant and an opium system, the close relation between a GABA beta-receptor and the opium drug acute abstinence, the advantages of the GABA beta-receptor stimulant reducing the exacting action of the opium drug, etc. The baclofen is concretely applied in the comprehensive treatments, such as opium drug detoxification (acute abstinence symptom), healing (protracted abstinence syndrome and overcoming psychological dependence), etc. The clinical trial shows that the invention not only develops the application range of traditional drugs, but also has the advantages of investment saving, the low cost of product, strong practicability, good effect, etc. The baclofen can be widely applied to the opium drug abstinence detoxification and healing treatment.

The invention discloses a health care wristband, and relates to daily living equipment. The health care wristband comprises an annular tube, an inner ring groove and an outer ring groove are fastened to form the annular tube, a plurality of small through holes are formed in the wall of the outer ring groove, volatilization blocks are laid in the inner ring groove and comprise substrate layers and traditional Chinese medicine functional component layers, the substrate layers are laminated on the inner wall of the inner ring groove through bottom layers, the traditional Chinese medicine functional component layers are applied to the substrate layers, functional components of the traditional Chinese medicine functional component layers comprise 1-5 parts of tea tree extracts, 1-5 parts of apple extracts, 1-5 parts of wormwood extracts, 1-5 parts of fructus momordicae extracts, 1-5 parts of isatis root extracts and 20-50 parts of nano-zinc oxide. Compared with the prior art, the health care wristband has the advantages that the traditional Chinese medicine functional components can achieve refreshing effects and bactericidal effects, toxic gas volatilization and psychological dependence are avoided, the functional components are sweet in smell and non-irritating, harmful substances in air can be absorbed and decomposed by the aid of the nano-zinc oxide, and the air is further cleaned.

Disclosed is a method for forcing killer rats to actively seek out young rats so as to prevent rodent damage. According to the method, specially-controlled drugs are added into meat of the young rats,and then the killer rats are fed with the meat, wherein the drugs can enable the killer rats to have strong physiological and psychological dependence and be addicted to the drugs quickly; the killerrats having strong addiction to the specially-controlled drugs are forced to try their best to seek out and eat the young rats in a region with the rodent damage under the guidance of a deep impression that 'the young rats are sources of the specially-controlled drugs', so as to meet their strong demands for the specially-controlled drugs; in this way, internal strife of rat groups is aggravated,the mortality of the rat groups is greatly increased, and the rodent damage prevention and treatment effect on the region with the rodent damage is improved. There are two measures to achieve the technical solution, one is cultivating the killer rats with the meat, mixed with the specially-controlled drugs, of the young rats in a feeding place, and the other is widely spreading meat baits, mixedwith the specially-controlled drugs, of the young rats in the region with the rodent damage to generally cultivate the killer rats.

The invention relates to an application of D-seromycin in preparing medicine for treating Morphine psychological dependence behavior caused by stress, which belongs to the medicine technical field. A glutamic acid system in brain plays an important role in drug addiction process, and N-methyl-D-aspartic acid (NMDA) receptor which can be combined with glutamic acid to play a physiological effect exists in central nervous system. The NMDA receptor can be functionally inhibited by acting on different recognition sites. At present more side effects are brought by completely inhibiting the NMDA receptor, so antagonist which not only can block the pathological activation of the NMDA receptor but also is free from influencing the physiological activity of the NMDA receptor is important to discover. DCS is a serine natural derivative and is combined with a glycine site in NMDA receptor NR1 subunit to play an effect of excitant, so that internal flow of calcium ions in cells can be increased, but no neurotoxicity is produced. Since the prepared medicine not only can partially excite the NMDA receptor, but also is free from influencing the physiological activity, the medicine has small side effect on the human body.

The invention relates to a traditional Chinese medicine preparation for treating psychogenic erectile dysfunction and a preparation method thereof, belonging to the technical field of biological traditional Chinese medicine preparations. The traditional Chinese medicine preparation for treating psychogenic erectile dysfunction comprises an ointment for treating psychogenic erectile dysfunction andgel for treating psychogenic erectile dysfunction, wherein the composition of the two comprises the following traditional Chinese medicine raw materials: hirudin freeze-dried powder, musk, safflower,ligusticum wallichii, asarum and ericarpium papaveris. The hirudin freeze-dried powder serves as a monarch drug, the musk, safflower, ligusticum wallichii and asarum are taken as the ministerial drug, and the pericarpium papaveris is taken as the adjuvant. The preparation method of the traditional Chinese medicine preparation for treating psychogenic erectile dysfunction comprises the following steps: a preparation method of the ointment for treating psychogenic erectile dysfunction and a preparation method of the gel for treating psychogenic erectile dysfunction. The hirudin freeze-dried powder serving as the monarch drug is matched with multiple auxiliary traditional Chinese medicinal materials to form the composition, and the traditional Chinese medicine preparation is used for treatment aiming at pathogenesis of the psychogenic erectile dysfunction, avoids physical and psychological dependence, is capable of treating both symptoms and root causes, stable in curative effect and high in cure rate, and does not cause any side effect when used for a long time.

Disclosed is a pharmaceutical composition for preventing and treating addiction to morphine or preventing and inhibiting the development of tolerance to the analgesic effects of morphine, containing berberine as an effective ingredient, wherein the berberine has an inhibitory effect versus psychological dependence on abused drugs such as morphine and the increase of spontaneous locomotor activity upon administration of the drugs, The pharmaceutical composition and a Coptis japonica plant extract of the present invention, which contain berberine, are highly effective in inhibiting the aforementioned symptoms of morphine addiction, and are thus useful for prevention and treatment of addiction to abused drugs such as morphine. In addition, the pharmaceutical composition additionally containing a pharmaceutical acceptable carrier can be applied to prevent and inhibit morphine tolerance caused by repeated administration of morphine, while not affecting the analgesic effects of morphine upon a single administration.

The invention relates to an extract of a plant raw material, and discloses an apocynum venetum extract, a preparation method thereof and application thereof in drug addiction treatment, getting rid of addiction to drugs, and resisting relapsing. The apocynum venetum extract is characterized in that the apocynum venetum extract is the total solid extracted from folium apocyni veneti or overground part of the apocynum venetum through water or other polar solvent. Matched with acceptable additives of medicines or foods, the extract can be prepared into various foods or medicines in forms of solid, half-solid, liquid or aerosol. The apocynum venetum extract can effectively and rapidly lower addiction to drugs, especially reduces harm of plant drugs such as opium, morphine, heroin and cocaine as well as chemical synthesis drugs such as methamphetamine to human bodies, can lower and relieve the toxicity, eliminates stubborn psychological dependence, improves sleeping quality, increases appetite, improves organism immunity, readjusts the functions of endorphin regulation system, and achieves the purposes of giving up drugs and resisting relapsing.

The invention relates to a cigarette quitting method. The cigarette quitting method comprises the following steps that S1, a doctor determines a smoking cessation target together with a smoker through motivated interviews and makes a smoking cessation plan; S2, the patient is completely withstood for about one week, smoking cannot be performed after complete withstood, and actions are started according to the plan in the step S1; S3, the time of the conversion period is 1 month, and the smoker is converted into a non-smoker in the mental state; S4, in the process of the step S1, the step S2 and the step S3, a traditional Chinese medicine extraction treatment method is adopted at the same time, and the body of the smoking cessation person is made to have aversion to the cigarette smell in the mode of smoking cessation snacks and smoking cessation stickers; and S5, in the process of the step S1, the step S2 and the step S3, smoking cessation psychological online and offline curriculum training is performed on the smoking cessation person at the same time. The method starts from the three aspects of physical dependence, habit dependence and psychological dependence of the smoking cessation person, traditional Chinese medicine product therapy, behavioral habit therapy and psychological cognition therapy are adopted to achieve successful smoking cessation, the smoking cessation effect is good, and the relapse rate is low.

The invention discloses a patch for heroin addiction withdrawal, a preparation method and an application thereof. The patch for heroin addiction withdrawal of the invention comprises a backing layer, a substrate layer, and a protection layer; the substrate layer of the patch comprises a main drug effective component of naltrexone hydrochloride, wherein naltrexone hydrochloride accounts for 30-55 wt% of the substrate layer; the substrate layer comprises 45-70 wt% of a film forming slow release carrier; the slow release carrier is acrylate copolymer. The patch for heroin addiction withdrawal of the invention is used for pasting on human body abdominal navel, adopts a mechanism method of percutaneous forced automatic drug administration, employs a therapy of psychological dependence resistance, has no side effect, and allows patients to work and study as normal people during detoxification process.

Disclosed is a pharmaceutical composition for preventing and treating addiction to morphine or preventing and inhibiting the development of tolerance to the analgesic effects of morphine, containing berberine as an effective ingredient, wherein the berberine has an inhibitory effect versus psychological dependence on abused drugs such as morphine and the increase of spontaneous locomotor activityupon administration of the drugs, The pharmaceutical composition and a Coptis japonica plant extract of the present invention, which contain berberine, are highly effective in inhibiting the aforementioned symptoms of morphine addiction, and are thus useful for prevention and treatment of addiction to abused drugs such as morphine. In addition, the pharmaceutical composition additionally containing a pharmaceutical acceptable carrier can be applied to prevent and inhibit morphine tolerance caused by repeated administration of morphine, while not affecting the analgesic effects of morphine upona single administration.